169 related articles for article (PubMed ID: 25959738)
21. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
[TBL] [Abstract][Full Text] [Related]
22. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
[TBL] [Abstract][Full Text] [Related]
23. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
Collins JW; Tyritzis S; Nyberg T; Schumacher M; Laurin O; Khazaeli D; Adding C; Jonsson MN; Hosseini A; Wiklund NP
Eur Urol; 2013 Oct; 64(4):654-63. PubMed ID: 23769588
[TBL] [Abstract][Full Text] [Related]
24. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
25. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
Lavery HJ; Martinez-Suarez HJ; Abaza R
BJU Int; 2011 Jun; 107(11):1802-5. PubMed ID: 21070571
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes.
Shao P; Meng X; Li J; Lv Q; Zhang W; Xu Z; Yin C
BJU Int; 2011 Jul; 108(1):124-8. PubMed ID: 20950309
[TBL] [Abstract][Full Text] [Related]
27. Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.
Siemens DR; Mackillop WJ; Peng Y; Wei X; Berman D; Booth CM
Urol Oncol; 2015 Oct; 33(10):425.e15-23. PubMed ID: 26199175
[TBL] [Abstract][Full Text] [Related]
28. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
[TBL] [Abstract][Full Text] [Related]
29. Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
Fransen van de Putte EE; Hermans TJ; Werkhoven Ev; Mertens LS; Meijer RP; Bex A; Wassenaar AE; van der Poel HG; van Rhijn BW; Horenblas S
Urol Oncol; 2015 Dec; 33(12):504.e19-24. PubMed ID: 26329817
[TBL] [Abstract][Full Text] [Related]
30. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
Jonsson MN; Adding LC; Hosseini A; Schumacher MC; Volz D; Nilsson A; Carlsson S; Wiklund NP
Eur Urol; 2011 Nov; 60(5):1066-73. PubMed ID: 21852033
[TBL] [Abstract][Full Text] [Related]
31. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
[TBL] [Abstract][Full Text] [Related]
32. Does extended lymphadenectomy increase the morbidity of radical cystectomy?
Brössner C; Pycha A; Toth A; Mian C; Kuber W
BJU Int; 2004 Jan; 93(1):64-6. PubMed ID: 14678370
[TBL] [Abstract][Full Text] [Related]
33. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
Fang AC; Ahmad AE; Whitson JM; Ferrell LD; Carroll PR; Konety BR
Cancer; 2010 Apr; 116(8):1901-8. PubMed ID: 20186823
[TBL] [Abstract][Full Text] [Related]
34. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
35. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
36. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
[TBL] [Abstract][Full Text] [Related]
37. Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years.
Xylinas E; Green DA; Otto B; Jamzadeh A; Kluth L; Lee RK; Robinson BD; Shariat SF; Scherr DS
Urology; 2013 Dec; 82(6):1323-9. PubMed ID: 24295248
[TBL] [Abstract][Full Text] [Related]
38. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
Perera M; McGrath S; Sengupta S; Crozier J; Bolton D; Lawrentschuk N
Nat Rev Urol; 2018 Nov; 15(11):686-692. PubMed ID: 30104615
[TBL] [Abstract][Full Text] [Related]
39. Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes.
Wang YC; Wu J; Dai B; Shen YJ; Ma CG; Ye DW; Zhu YP
World J Surg Oncol; 2019 Dec; 17(1):225. PubMed ID: 31864368
[TBL] [Abstract][Full Text] [Related]
40. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute.
Guru KA; Kim HL; Piacente PM; Mohler JL
Urology; 2007 Mar; 69(3):469-74. PubMed ID: 17382147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
